Literature DB >> 12402587

Comparison of quality-of-life assessment in Russia and the United States in chronic peritoneal dialysis patients.

Peter H Juergensen1, Alexander Zemchenkov, Susan Watnick, Susan Finkelstein, Diane Wuerth, Fredric O Finkelstein.   

Abstract

Numerous reports of quality-of-life data in chronic peritoneal dialysis (CPD) patients in the United States and Western Europe use the short form questionnaire (SF-36). Few centers in Europe have reported data examining the incidence of depression in CPD patients. Depression has been shown to correlate with morbidity and mortality in dialysis patients. A high incidence of clinical depression is seen in end-stage renal disease patients in the United States. We thought it could be important to compare depression measurements between the United States and European countries. Quality-of-life data of the peritoneal dialysis patients from the New Haven continuous ambulatory peritoneal dialysis (CAPD) unit and from the New Technology Center at Hospital #31 in St. Petersburg were compared. The Beck Depression Inventory (BDI) and the SF-36, which includes the mental component score (MCS) and the physical component score (PCS), were administered to the patients. The study participants included 147 Russian and 96 U.S. patients. The BDI, PCS, and MCS scores were similar in both groups. The BDI scores in the Russian patients indicated that a high incidence of clinical depression likely exists in that patient population. The utility of the BDI in assessing quality-of-life issues in Europe and Russia requires further evaluation.

Entities:  

Mesh:

Year:  2002        PMID: 12402587

Source DB:  PubMed          Journal:  Adv Perit Dial        ISSN: 1197-8554


  3 in total

1.  Sertraline treatment is associated with an improvement in depression and health-related quality of life in chronic peritoneal dialysis patients.

Authors:  Huseyin Atalay; Yalcin Solak; Murat Biyik; Zeynep Biyik; Mehdi Yeksan; Faruk Uguz; Ibrahim Guney; Halil Zeki Tonbul; Suleyman Turk
Journal:  Int Urol Nephrol       Date:  2009-12-02       Impact factor: 2.370

2.  Long-term efficacy of intermittent peritoneal dialysis using various doses.

Authors:  Zhi-Yong Zhang; Chun-Hua Zhou; Ming-Xu Li; Yong-Wu Yu
Journal:  Exp Ther Med       Date:  2011-12-30       Impact factor: 2.447

3.  Validation of an instrument for measuring satisfaction of patients undergoing hemodialysis.

Authors:  Mauricio Sanabria-Arenas; Julia Tobón- Marín; María Claudia Certuche-Quintana; Ricardo Sánchez-Pedraza
Journal:  BMC Health Serv Res       Date:  2017-05-03       Impact factor: 2.655

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.